Cargando…

Alcohol Induces More Severe Fatty Liver Disease by Influencing Cholesterol Metabolism

Objectives. Fatty liver disease (FLD) is a major cause of morbidity and mortality worldwide. Dietary cholesterol and alcohol consumption are important risk factors for the progression of FLD, but whether and how alcohol induces more severe FLD with cholesterol ingestion remain unclear. Herein, we ma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bo, Lei, Shan-Shan, Su, Jie, Cai, Xia-Miao, Xu, Hao, He, Xinglishang, Chen, Ye-Hui, Lu, Hai-Xia, Li, He, Qian, Liu-Qing, Zheng, Xiang, Lv, Gui-Yuan, Chen, Su-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390266/ https://www.ncbi.nlm.nih.gov/pubmed/30891077 http://dx.doi.org/10.1155/2019/7095684

Ejemplares similares

Dendrobium officinale Regulates Fatty Acid Metabolism to Ameliorate Liver Lipid Accumulation in NAFLD Mice
por: Lei, Shan-Shan, et al.
Publicado: (2021)

Hypertensive Rats Treated Chronically With N(ω)-Nitro-L-Arginine Methyl Ester (L-NAME) Induced Disorder of Hepatic Fatty Acid Metabolism and Intestinal Pathophysiology
por: Li, Bo, et al.
Publicado: (2020)

Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study
por: Wang, Kun, et al.
Publicado: (2018)

Beneficial Effects of Macroporous Resin Extract of Dendrobium candidum Leaves in Rats with Hyperuricemia Induced by a High-Purine Diet
por: Lou, Xiao-Jing, et al.
Publicado: (2020)

Disturbances in Cholesterol Homeostasis and Non-alcoholic Fatty Liver Diseases
por: Malhotra, Pooja, et al.
Publicado: (2020)

Lactobacillus oris improves non-alcoholic fatty liver in mice and inhibits endogenous cholesterol biosynthesis
por: Zhao, Yiming, et al.
Publicado: (2023)

Association Between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Risk of Non-alcoholic Fatty Liver Disease: A Cross-Sectional Study
por: Wang, Liping, et al.
Publicado: (2022)

Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants
por: Xia, Yang, et al.
Publicado: (2021)

Linarin Enriched Extract Attenuates Liver Injury and Inflammation Induced by High-Fat High-Cholesterol Diet in Rats
por: Zhuang, Zhen-Jie, et al.
Publicado: (2017)

The change of non-alcoholic fatty liver disease is associated with risk of incident diabetes
por: Chen, Congling, et al.
Publicado: (2023)

P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
por: Xia, Guo-Qing, et al.
Publicado: (2022)

Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
por: Yan, Hong-Mei, et al.
Publicado: (2015)

The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway
por: Lv, Juan, et al.
Publicado: (2022)

Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors
por: Huang, Xin-Juan, et al.
Publicado: (2023)

Association of leukocyte telomere length with non-alcoholic fatty liver disease in patients with type 2 diabetes
por: Zhang, Min, et al.
Publicado: (2019)

Plant-based diets, genetic predisposition and risk of non-alcoholic fatty liver disease
por: Lv, Yanling, et al.
Publicado: (2023)

Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study
por: Ren, Xiao Yu, et al.
Publicado: (2019)

Cholesterol and saturated fatty acids synergistically promote the malignant progression of prostate cancer
por: Wang, Xiaoying, et al.
Publicado: (2021)

Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease
por: Cheng, Yiping, et al.
Publicado: (2023)

Protective effect of probiotics in patients with non-alcoholic fatty liver disease
por: Cai, Gen-shen, et al.
Publicado: (2020)

Natural flavonoids: Potential therapeutic strategies for non-alcoholic fatty liver disease
por: Tan, Panli, et al.
Publicado: (2022)

New risk‐scoring system including non‐alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort
por: Chen, Guang‐Yu, et al.
Publicado: (2015)

Analysis of non-alcoholic fatty liver disease microRNA expression spectra in rat liver tissues
por: Nie, Jiao, et al.
Publicado: (2018)

Cholesterol-Induced Non-Alcoholic Fatty Liver Disease and Atherosclerosis Aggravated by Systemic Inflammation
por: Kim, Eung Ju, et al.
Publicado: (2014)

Anti-inflammatory effect of Ganluyin, a Chinese classic prescription, in chronic pharyngitis rat model
por: Chen, Ye-Hui, et al.
Publicado: (2020)

Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat
por: Comhair, Tine M, et al.
Publicado: (2011)

Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
por: Stice, Camilla P., et al.
Publicado: (2018)

A potential link between plasma short-chain fatty acids, TNF-α level and disease progression in non-alcoholic fatty liver disease: A retrospective study
por: Xiong, Jing, et al.
Publicado: (2022)

Establishment of a novel non-alcoholic fatty liver disease model using cholesterol-fed rabbits with reference to the potential role of endoplasmic reticulum stress
por: Wang, Yanli, et al.
Publicado: (2018)

Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment
por: Che, Wensheng, et al.
Publicado: (2022)

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway
por: Li, Qian, et al.
Publicado: (2022)

Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease
por: Anekwe, Chika V, et al.
Publicado: (2020)

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease
por: Pastori, Daniele, et al.
Publicado: (2018)

Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents
por: Chin, Justin, et al.
Publicado: (2020)

Non-Alcoholic Fatty Liver Disease Is an Independent Risk Factor for LDL Cholesterol Target Level
por: Lee, Jun-Hyuk, et al.
Publicado: (2021)

Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease
por: Zhang, Linqiang, et al.
Publicado: (2015)

Complements are involved in alcoholic fatty liver disease, hepatitis and fibrosis
por: Lin, Cheng-Jie, et al.
Publicado: (2018)

Pediatric non alcoholic fatty liver disease: more on novel treatment targets
por: Vajro, Pietro, et al.
Publicado: (2013)

Development of Thyroid Hormones and Synthetic Thyromimetics in Non-Alcoholic Fatty Liver Disease
por: Zhao, Man, et al.
Publicado: (2022)

Meta-analysis reveals up-regulation of cholesterol processes in non-alcoholic and down-regulation in alcoholic fatty liver disease
por: Wruck, Wasco, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_931sru430av793so5evum2gtn1